These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 108743)

  • 1. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration.
    Rebec GV; Segal DS
    Psychopharmacology (Berl); 1979 Mar; 62(1):101-2. PubMed ID: 108743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and experimental factors in the behavioral response to repeated amphetamine.
    Browne RG; Segal DS
    Pharmacol Biochem Behav; 1977 May; 6(5):545-52. PubMed ID: 561406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.
    Segal DS; Mandell AJ
    Pharmacol Biochem Behav; 1974; 2(2):249-55. PubMed ID: 4857295
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.
    Greenberg BD; Segal DS
    Pharmacol Biochem Behav; 1985 Jul; 23(1):99-105. PubMed ID: 4041046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 7. Abatement of stimulus perseveration following repeated d-amphetamine treatment: absence of behaviorally augmented tolerance.
    Kokkinidis L; Anisman H
    Pharmacol Biochem Behav; 1978 May; 8(5):557-63. PubMed ID: 566934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perseveration and rotational behavior elicited by d-amphetamine in a Y-maze exploratory task: differential effects of intraperitoneal and unilateral intraventricular administration.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1977 Apr; 52(2):123-8. PubMed ID: 407596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of d- and l-amphetamine on the open field performance of rats.
    Dandiya PC; Kulkarni SK
    Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of the behavioral effects of amphetamine in rats by clonidine.
    Mueller K; Nyhan WL
    Eur J Pharmacol; 1982 Sep; 83(3-4):339-42. PubMed ID: 6293845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic ICV leptin infusion on motor-activating effects of D-amphetamine in food-restricted and ad libitum fed rats.
    Hao J; Cabeza de Vaca S; Carr KD
    Physiol Behav; 2004 Dec; 83(3):377-81. PubMed ID: 15581659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further analysis of the resistance of the diabetic rat to d-amphetamine.
    Marshall JF
    Pharmacol Biochem Behav; 1978 Mar; 8(3):281-6. PubMed ID: 565933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chronic amphetamine in BALB/cBy mice, a strain that is not stimulated by acute administration of amphetamine.
    Logan L; Seale TW; Cao W; Carney JM
    Pharmacol Biochem Behav; 1988 Nov; 31(3):675-82. PubMed ID: 3251250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of amphetamine effects by intracerebrally administered anticholinergic agents.
    Costall B; Naylor RJ
    Life Sci I; 1972 Mar; 11(5):239-53. PubMed ID: 4675889
    [No Abstract]   [Full Text] [Related]  

  • 17. Diminished reaction to a novel stimulus during amphetamine withdrawal in rats.
    Schreiber H; Bell R; Conely L; Kufner M; Palet J; Wright L
    Pharmacol Biochem Behav; 1976 Dec; 5(6):687-90. PubMed ID: 1035805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats.
    Thornhill JA; Hirst M; Gowdey CW
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1170-8. PubMed ID: 562704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.